Merck & Co., Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. April 14, 2025 Deadline to file Lead Plaintiff Motion.

Core Viewpoint - Merck & Co., Inc. is facing a class action lawsuit from investors due to a significant drop in stock price following the company's announcement that it would not meet its projected $11 billion revenue from Gardasil sales by 2030 [1][4]. Group 1: Class Action Details - The class action represents investors who purchased Merck securities between February 3, 2022, and February 3, 2025, with a deadline to file a lead plaintiff motion by April 14, 2025 [1]. - Investors are encouraged to contact the Portnoy Law Firm for a complimentary case evaluation and to discuss their legal rights [2]. Group 2: Financial Projections and Impact - The complaint highlights that Merck had projected $11 billion in revenue from Gardasil sales by 2030, supported by optimistic forecasts regarding demand in China [3]. - On February 4, 2025, Merck announced it would halt Gardasil shipments to China, leading to a stock price drop from $99.79 to $90.74 per share, a decline of over 9% in one day [4].